Fatty Acid Synthase Antibody, anti-human, PE, REAfinity™, 200 µL
文献支持

Fatty Acid Synthase Antibody,

anti-human, PE, REAfinity™, 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-137-707
  • 2025年12月09日
  • MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      Fatty Acid Synthase

    • 亚型

      recombinant human IgG1

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REA1429

    • 标记物

      PE

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi biotec

    • 宿主

      human cell line

    • 应用范围

      MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 浓度

      1:50

    • 抗体英文名

      Fatty Acid Synthase Antibody, anti-human, REAfinity™

    • 抗体名

      Fatty Acid Synthase Antibody, anti-human, REAfinity™

    • 规格

      200 µL

    Identification and enumeration of Fatty Acid Synthase+ cells by flow cytometryClone REA1429 recognizes the Fatty Acid Synthase, a multifunctional enzyme that catalyzes the de novo biosynthesis of long-chain saturated fatty acids. Fatty Acid Synthase contains 7 catalytic activities and a site for the binding of the acyl carrier protein (ACP). It is encoded by the FASN gene. FASN enhances the generation of additional energy and facilitates the formation of cell membranes, promoting cancer proliferation and progression. Fatty acid synthetase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. |

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Xiao, Y. et al. (2024) FASN contributes to the pathogenesis of lupus by promoting TLR-mediated activation of macrophages and dendritic cells. Int. Immunopharmacol. 142 (PT B): 113136–113136. | Papulino, C. et al. (2024) Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer. J Transl Med. 22 (1): 676–676. | Elahi, L. S. et al. (2024) Valproic acid targets IDH1 mutants through alteration of lipid metabolism. NPJ Metab Health Dis 2 (1): 20–20.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月10日询价
    ¥22
    艾美捷科技有限公司
    2025年07月13日询价
    ¥5900
    GeneTex
    2025年07月16日询价
    ¥2000
    北京博蕾德生物科技有限公司
    2025年07月16日询价
    文献支持
    Fatty Acid Synthase Antibody, anti-human, PE, REAfinity™, 200 µL
    询价